DVS Sciences CyTOF® Mass Cytometer Featured in Paper Selected to Receive the Cytometry A 2012 Best Paper Award

SUNNYVALE, Calif. - Monday, May 20th 2013 [ME NewsWire]

(BUSINESS WIRE)-- DVS Sciences, Inc., a privately held innovator of novel multi-parameter single-cell analyzers and reagents for biological research technology, today announced that its CyTOF® Mass Cytometer was used in an award winning paper.

The paper, Single-Cell Mass Cytometry Adapted to Measurements of the Cell Cycle, published in Cytometry Part A (81A:552-566,2012) and authored by G.K. Behbehani, S.C. Bendall, M.R. Clutter, W.J. Fanti, G.P. Nolan, describes a pioneering method using Mass Cytometry to delineate cell cycle distributions of both normal and cancer cell populations while simultaneously immunophenotyping each cell population with 25 surface markers. The paper also describes how the technology was able to study the cell cycle phases of cells spanning the hematopoietic hierarchy in healthy human bone marrow as a prelude to later studies with cancers and other disorders of this lineage.

The Cytometry A 2012 Best Paper Award has been announced by the International Society for the Advancement of Cytometry (ISAC) and will be presented to the authors at the CYTO 2013 meeting held May 18th to 22nd, 2013 in San Diego, CA.

DVS Sciences recently launched its CyTOF® 2 Mass Cytometer and new MaxPar® Panel Kits. These innovative new products will be on display at the CYTO 2013 show at booth #530.

For more information about the CyTOF platform and MaxPar panels and reagents, please visit the DVS Sciences website at www.DVSsciences.com.

About DVS Sciences, Inc.

DVS Sciences, Inc. manufactures and globally distributes novel bioanalytical solutions for use in biomarker discovery, biological research and potential future use in clinical applications. The patented multi-parameter technology comprises a high-throughput mass cytometer for quantitative individual cell analysis, CyTOF, and the MaxPar suite of stable isotope-tagged panel kits and reagents. The CyTOF platform overcomes the limitations of conventional flow cytometry, simplifies sample preparation, and can simultaneously identify up to 100 biomarkers with high resolution and wide dynamic range. CyTOF systems are installed in leading laboratories across the U.S., Canada, Europe and Asia. DVS Sciences has its global headquarters and reagent kit manufacturing in Sunnyvale, California with a R&D and instrument manufacturing facility near Toronto, Canada and a sales/support office in the UK. 

Contacts

DVS Sciences, Inc.

Nicole Ellis-Ovadia, +1 408-900-7224

Nicole.ovadia@dvssciences.com